Literature DB >> 19877970

Artemisinin combination therapy for malaria: beyond good efficacy.

Ric N Price, Nicholas M Douglas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19877970      PMCID： PMC4627500          DOI： 10.1086/647947

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  13 in total

1.  Averting a malaria disaster.

Authors:  N J White; F Nosten; S Looareesuwan; W M Watkins; K Marsh; R W Snow; G Kokwaro; J Ouma; T T Hien; M E Molyneux; T E Taylor; C I Newbold; T K Ruebush; M Danis; B M Greenwood; R M Anderson; P Olliaro
Journal:  Lancet       Date:  1999-06-05       Impact factor: 79.321

2.  Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria.

Authors:  F Ezzet; M van Vugt; F Nosten; S Looareesuwan; N J White
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

3.  Antimalarial drug resistance and combination chemotherapy.

Authors:  N White
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

4.  Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.

Authors:  A Ratcliff; H Siswantoro; E Kenangalem; R Maristela; R M Wuwung; F Laihad; E P Ebsworth; N M Anstey; E Tjitra; R N Price
Journal:  Lancet       Date:  2007-03-03       Impact factor: 79.321

5.  Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.

Authors:  Issaka Zongo; Grant Dorsey; Noel Rouamba; Christian Dokomajilar; Yves Séré; Philip J Rosenthal; Jean Bosco Ouédraogo
Journal:  Clin Infect Dis       Date:  2007-10-22       Impact factor: 9.079

6.  Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria.

Authors:  Te-Yu Hung; Timothy M E Davis; Kenneth F Ilett; Harin Karunajeewa; Sean Hewitt; Mey Bouth Denis; Chiv Lim; Doung Socheat
Journal:  Br J Clin Pharmacol       Date:  2004-03       Impact factor: 4.335

7.  A trial of combination antimalarial therapies in children from Papua New Guinea.

Authors:  Harin A Karunajeewa; Ivo Mueller; Michele Senn; Enmoore Lin; Irwin Law; P Servina Gomorrai; Olive Oa; Suzanne Griffin; Kaye Kotab; Penias Suano; Nandao Tarongka; Alice Ura; Dulcie Lautu; Madhu Page-Sharp; Rina Wong; Sam Salman; Peter Siba; Kenneth F Ilett; Timothy M E Davis
Journal:  N Engl J Med       Date:  2008-12-08       Impact factor: 91.245

Review 8.  Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities.

Authors:  Christopher J M Whitty; Clare Chandler; Evelyn Ansah; Toby Leslie; Sarah G Staedke
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

9.  Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial.

Authors:  Moses R Kamya; Adoke Yeka; Hasifa Bukirwa; Myers Lugemwa; John B Rwakimari; Sarah G Staedke; Ambrose O Talisuna; Bryan Greenhouse; François Nosten; Philip J Rosenthal; Fred Wabwire-Mangen; Grant Dorsey
Journal:  PLoS Clin Trials       Date:  2007-05-18

10.  Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.

Authors:  Adoke Yeka; Grant Dorsey; Moses R Kamya; Ambrose Talisuna; Myers Lugemwa; John Bosco Rwakimari; Sarah G Staedke; Philip J Rosenthal; Fred Wabwire-Mangen; Hasifa Bukirwa
Journal:  PLoS One       Date:  2008-06-11       Impact factor: 3.240
View more
  10 in total

Review 1.  Treating uncomplicated malaria in children: comparing artemisinin-based combination therapies.

Authors:  Adoke Yeka; Jamal C Harris
Journal:  Curr Opin Pediatr       Date:  2010-12       Impact factor: 2.856

2.  Dual symbiosis between Piriformospora indica and Azotobacter chroococcum enhances the artemisinin content in Artemisia annua L.

Authors:  Monika Arora; Parul Saxena; Devendra Kumar Choudhary; Malik Zainul Abdin; Ajit Varma
Journal:  World J Microbiol Biotechnol       Date:  2016-01-08       Impact factor: 3.312

3.  An Economic Evaluation of the Posttreatment Prophylactic Effect of Dihydroartemisinin-Piperaquine Versus Artemether-Lumefantrine for First-Line Treatment of Plasmodium falciparum Malaria Across Different Transmission Settings in Africa.

Authors:  Johannes Pfeil; Steffen Borrmann; Quique Bassat; Modest Mulenga; Ambrose Talisuna; Yesim Tozan
Journal:  Am J Trop Med Hyg       Date:  2015-08-03       Impact factor: 2.345

Review 4.  Host targeting of virulence determinants and phosphoinositides in blood stage malaria parasites.

Authors:  Souvik Bhattacharjee; Robert V Stahelin; Kasturi Haldar
Journal:  Trends Parasitol       Date:  2012-10-16

5.  The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam.

Authors:  Nguyen Xuan Thanh; Trieu Nguyen Trung; Nguyen Chinh Phong; Huynh Hong Quang; Bui Dai; G Dennis Shanks; Marina Chavchich; Michael D Edstein
Journal:  Malar J       Date:  2012-06-28       Impact factor: 2.979

6.  Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics.

Authors:  Nicholas M Douglas; François Nosten; Elizabeth A Ashley; Lucy Phaiphun; Michèle van Vugt; Pratap Singhasivanon; Nicholas J White; Ric N Price
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

7.  Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children.

Authors:  Adoke Yeka; James Tibenderana; Jane Achan; Umberto D'Alessandro; Ambrose O Talisuna
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

8.  Metabolic analyses elucidate non-trivial gene targets for amplifying dihydroartemisinic acid production in yeast.

Authors:  Ashish Misra; Matthew F Conway; Joseph Johnnie; Tabish M Qureshi; Bao Lige; Anne M Derrick; Eddy C Agbo; Ganesh Sriram
Journal:  Front Microbiol       Date:  2013-07-26       Impact factor: 5.640

9.  Development of Chemical Entities Endowed with Potent Fast-Killing Properties against Plasmodium falciparum Malaria Parasites.

Authors:  Alexios N Matralis; Adnan Malik; Maria Penzo; Inmaculada Moreno; Maria J Almela; Isabel Camino; Benigno Crespo; Anas Saadeddin; Sonja Ghidelli-Disse; Lourdes Rueda; Felix Calderon; Simon A Osborne; Gerard Drewes; Markus Böesche; Elena Fernández-Álvaro; Jose Ignacio Martin Hernando; David A Baker
Journal:  J Med Chem       Date:  2019-10-14       Impact factor: 7.446

10.  Usnic acid modifies MRSA drug resistance through down-regulation of proteins involved in peptidoglycan and fatty acid biosynthesis.

Authors:  Sneha Sinha; Vivek Kumar Gupta; Parmanand Kumar; Rajiv Kumar; Robin Joshi; Anirban Pal; Mahendra P Darokar
Journal:  FEBS Open Bio       Date:  2019-09-30       Impact factor: 2.693
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.